Amneal Pharmaceuticals Inc (AMRX)
8.335
-0.06
(-0.77%)
USD |
NASDAQ |
Nov 05, 11:46
Amneal Pharmaceuticals Max Drawdown (5Y): 94.77% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 94.77% |
| September 30, 2024 | 94.77% |
| August 31, 2024 | 94.77% |
| July 31, 2024 | 94.77% |
| June 30, 2024 | 94.77% |
| May 31, 2024 | 94.77% |
| April 30, 2024 | 94.77% |
| March 31, 2024 | 94.77% |
| February 29, 2024 | 94.77% |
| January 31, 2024 | 94.77% |
| December 31, 2023 | 94.77% |
| November 30, 2023 | 94.77% |
| October 31, 2023 | 94.77% |
| September 30, 2023 | 94.77% |
| August 31, 2023 | 94.77% |
| July 31, 2023 | 94.77% |
| June 30, 2023 | 94.77% |
| May 31, 2023 | 94.77% |
| April 30, 2023 | 94.77% |
| March 31, 2023 | 94.77% |
| February 28, 2023 | 91.92% |
| January 31, 2023 | 91.92% |
| December 31, 2022 | 91.92% |
| November 30, 2022 | 91.92% |
| October 31, 2022 | 91.92% |
| Date | Value |
|---|---|
| September 30, 2022 | 91.68% |
| August 31, 2022 | 91.06% |
| July 31, 2022 | 90.56% |
| June 30, 2022 | 90.56% |
| May 31, 2022 | 90.56% |
| April 30, 2022 | 90.56% |
| March 31, 2022 | 90.56% |
| February 28, 2022 | 90.56% |
| January 31, 2022 | 90.56% |
| December 31, 2021 | 90.56% |
| November 30, 2021 | 90.56% |
| October 31, 2021 | 90.56% |
| September 30, 2021 | 90.56% |
| August 31, 2021 | 90.56% |
| July 31, 2021 | 90.56% |
| June 30, 2021 | 90.56% |
| May 31, 2021 | 90.56% |
| April 30, 2021 | 90.56% |
| March 31, 2021 | 90.56% |
| February 28, 2021 | 90.56% |
| January 31, 2021 | 90.56% |
| December 31, 2020 | 90.56% |
| November 30, 2020 | 90.56% |
| October 31, 2020 | 90.56% |
| September 30, 2020 | 90.56% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
90.56%
Minimum
Nov 2019
94.77%
Maximum
Mar 2023
92.11%
Average
90.56%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Eli Lilly and Co | 22.48% |
| Nutriband Inc | 95.27% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 4.90 |
| Beta (5Y) | 1.174 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 57.18% |
| Historical Sharpe Ratio (5Y) | 0.3508 |
| Historical Sortino (5Y) | 0.5852 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.42% |